LighthouseAI, a company involved with compliance solutions for the pharmaceutical supply chain, reported a $2.25 million investment led by Healthy Ventures with participation from Bertelsmann Next. The funding, part of an ongoing $3.25 million seed round, aims to fuel the growth and development of LighthouseAI’s product suite.

The investment funds will be directed to enhance features and functionalities of LighthouseAI, scale operations to better serve the market, and penetrate new segments within the industry.

LighthouseAI’s product suite is engineered to automate pharmaceutical supply chain compliance for professionals who are responsible for compliance with federal and state regulations.

According to the company, regulation of the pharmaceutical supply chain has expanded extensively over the past decades as fallout from counterfeit schemes, tragedies resulting from poor compounding practices, the opioid epidemic, drug pricing expansion, drug shortages and more have brought extensive public and political scrutiny.

LighthouseAI’s product suite, rooted in the rapidly growing RegTech space, is specifically designed to overcome risk and cost associated with compliance using artificial intelligence to identify facility-specific requirements and automate regulatory surveillance across all state and federal jurisdictions, tailored to a user’s business model and product portfolio. As the Intelligence product solution identifies these requirements, LighthouseAI Management provides a system for efficient tracking and handling of responses, including secure uploading and storage of crucial documents, task management, and activity-level tracking, enabling the user to manage all related activities and obligations.

“With this investment, we’re enhancing our technology offerings and shaping the future of pharmaceutical compliance,” said Sumeet Singh, CEO of LighthouseAI. “Our momentum is strong, leveraging our seven years of thought leadership in this space with new clients adopting our technology and current clients transitioning to our latest solutions.”